Insomnia

F5_INSOMNIA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F51.0, G47.0 Cause of death: ICD-10 — F51.0, G47.0 2 out of 7 registries used, show all original rules.	7090
4. Check minimum number of events None	7090
5. Include endpoints None	7090
6. Filter based on genotype QC (FinnGen only)	7090

Control definitions (FinnGen only)

Control exclude: F5_SLEEP

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	F5_INSOMNIA
CONTROL_EXCLUDE	F5_SLEEP
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F510\|G470
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F510\|G470
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Insomnia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	47561	25957	21322
Only index persons	45332	25198	20134
Unadjusted period prevalence (%)
Whole population	0.67	0.74	0.60
Only index persons	0.86	0.93	0.77
Median age at first event (years)
Whole population	45.75	46.60	44.81
Only index persons	45.53	46.40	44.44

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7090	4574	2516
Unadjusted period prevalence (%)	1.40	1.56	1.11
Median age at first event (years)	49.38	47.83	52.20

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6042: Matched controls
60428

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.6

323.0

1314

3419

F32.9

ICD-10 Finland

Depressive episode, unspecified

5.0

323.0

1791

4659

N06AX11

ATC

mirtazapine; oral

9.5

323.0

4240

11938

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

5.3

323.0

1441

3375

N06AX05

ATC

trazodone; oral

12.8

323.0

629

542

F51.0

ICD-10 Finland

Nonorganic insomnia

146.7

323.0

5522

4071

N05BA04

ATC

oxazepam; oral

5.0

323.0

2801

8848

N06AB10

ATC

escitalopram; oral

3.6

323.0

2186

8232

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

18.1

323.0

961

624

N05CF02

ATC

zolpidem; oral

4.8

323.0

2114

6116

N06AB04

ATC

citalopram; systemic

3.6

323.0

2054

7609

N05AH03

ATC

olanzapine; systemic

7.6

323.0

1134

1772

N05CD07

ATC

temazepam; oral

5.2

323.0

1216

2780

P06

ICPC

Sleep disturbance

4.8

323.0

1251

3114

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

32.0

323.0

907

331

N06AX16

ATC

venlafaxine; oral

4.4

323.0

1714

5038

N05AA02

ATC

levomepromazine; systemic

9.7

323.0

780

911

N05AH04

ATC

quetiapine; oral

9.8

323.0

3145

6027

N05CF01

ATC

zopiclone; oral

5.6

323.0

3267

10498

N06AX03

ATC

mianserin; oral

8.0

304.9

740

1038

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

5.2

302.4

1043

2325

N05BA01

ATC

diazepam; systemic, rectal

4.1

289.0

1325

3917

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

5.2

284.7

979

2164

N06AB06

ATC

sertraline; oral

4.0

282.5

1296

3825

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

4.3

273.6

1171

3232

N06AX21

ATC

duloxetine; oral

4.1

270.3

1199

3418

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

4.3

256.7

1091

2975

N06AA12

ATC

doxepin; systemic

6.9

251.1

673

1080

N03AX16

ATC

pregabalin; oral

3.0

250.1

1823

7598

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

5.9

243.5

740

1399

N06AB03

ATC

fluoxetine; oral

3.6

239.1

1253

4081

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

15.8

238.6

402

272

N05AX08

ATC

risperidone; systemic

4.8

230.8

856

2024

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

5.0

230.7

817

1839

N06AA06

ATC

trimipramine; systemic

10.5

226.8

462

472

C07AA05

ATC

propranolol; systemic

2.9

226.8

1727

7325

N06AX12

ATC

bupropion; oral

4.4

212.3

850

2160

N05AX12

ATC

aripiprazole; systemic

5.9

212.1

636

1174

F41.1

ICD-10 Finland

Generalized anxiety disorder

5.1

210.8

730

1595

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.6

210.6

664

1303

F29

ICD-10 Finland

Unspecified nonorganic psychosis

6.1

209.4

613

1097

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.8

199.3

945

2793

N03AG01

ATC

valproic acid; systemic, rectal

4.7

198.5

741

1749

N05BA12

ATC

alprazolam; oral

3.6

194.1

994

3128

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

5.4

192.7

629

1280

N03AX09

ATC

lamotrigine; oral

4.9

191.5

676

1501

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

7.1

190.3

493

745

R53

ICD-10 Finland

Malaise and fatigue

2.7

182.9

1578

7071

N05AF03

ATC

chlorprothixene; systemic

7.4

178.2

449

650

N03AE01

ATC

clonazepam; systemic

4.8

177.9

641

1450

N06AX22

ATC

agomelatine; oral

8.3

172.7

401

511

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.2

165.9

697

1831

P01

ICPC

Feeling anxious/nervous/tense

2.9

162.6

1120

4326

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

282.0

161.4

164

N06AX26

ATC

vortioxetine; oral

4.1

160.9

683

1809

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

6.6

159.2

436

708

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.5

158.5

504

988

N03AX12

ATC

gabapentin; oral

2.8

155.0

1163

4727

G47.3

ICD-10 Finland

Sleep apnoea

2.5

149.0

1445

6790

N06AA09

ATC

amitriptyline; systemic

3.4

147.3

787

2522

P29

ICPC

Psychological sympt/compl other

3.8

145.0

679

1953

G47.9

ICD-10 Finland

Sleep disorder, unspecified

7.7

143.4

349

477

SPAT1240

SPAT

Therapeutic discussion

2.8

142.1

1063

4288

F34.1

ICD-10 Finland

Dysthymia

5.2

141.0

470

969

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

6.8

140.7

374

581

N05BA06

ATC

lorazepam; systemic, sublingual

4.9

139.4

486

1052

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

6.0

137.2

404

718

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

136.1

2432

15017

P76

ICPC

Depressive disorder

3.5

131.7

681

2117

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

6.1

131.0

379

658

Z71.8

ICD-10 Finland

Other specified counselling

2.2

130.8

1749

9513

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

7.2

129.9

330

480

P03

ICPC

Feeling depressed

2.9

129.1

910

3518

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.2

128.4

771

2677

N02AX02

ATC

tramadol; systemic, rectal

2.0

127.0

2487

15792

M79.6

ICD-10 Finland

Pain in limb

2.0

127.0

2234

13601

R51.80

ICD-10 Finland

Headache

2.5

126.3

1193

5465

N05BE01

ATC

buspirone; oral

5.8

124.7

375

683

A02BC02

ATC

pantoprazole; systemic

1.9

123.2

3744

27813

F51

ICD-10 Finland

Nonorganic sleep disorders

4.9

122.8

429

928

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

7.9

122.7

293

388

N05AB03

ATC

perphenazine; systemic, rectal

5.2

122.0

405

828

N06AB05

ATC

paroxetine; oral

3.5

120.9

616

1887

IGY02

NOMESCO Finland

Psychiatric monitoring contact

6.2

120.7

343

581

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

6.7

120.2

320

497

P74

ICPC

Anxiety disorder/anxiety state

4.3

118.5

473

1170

F32.1

ICD-10 Finland

Moderate depressive episode

3.5

116.6

603

1866

P99

ICPC

Psychological disorders other

5.2

112.7

372

755

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

6.3

112.5

314

519

N04BC05

ATC

pramipexole; oral

3.6

109.2

538

1599

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

4.0

109.1

467

1231

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

5.8

108.3

325

589

N05AN01

ATC

lithium; oral

5.6

106.9

330

619

M54.5

ICD-10 Finland

Low back pain

1.9

106.5

2129

13369

AA1AD

NOMESCO Finland

CT of head and brain

2.2

103.1

1311

6852

R42

ICD-10 Finland

Dizziness and giddiness

2.2

102.3

1273

6587

F60.9

ICD-10 Finland

Personality disorder, unspecified

7.9

102.3

244

322

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.0

102.1

263

389

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

994.7

100.4

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

100.2

1415

7725

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

8.1

99.1

231

294

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

5.1

98.3

331

685

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

96.5

1614

9407

N07BB01

ATC

disulfiram; oral

3.9

96.4

431

1177

G44.2

ICD-10 Finland

Tension-type headache

2.3

96.2

1002

4752

R06.0

ICD-10 Finland

Dyspnoea

2.1

95.9

1404

7757

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

7.8

95.6

229

304

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

95.3

1484

8403

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

6.3

95.2

266

440

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

94.3

2762

19483

F61.0

ICD-10 Finland

Mixed personality disorders

5.9

93.7

274

480

L03

ICPC

Low back symptom/complaint

2.0

93.4

1540

8908

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.8

93.1

278

500

N02BE01

ATC

paracetamol; systemic, rectal

2.0

93.0

5023

43062

F31.8

ICD-10 Finland

Other bipolar affective disorders

5.8

92.6

276

495

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

6.0

92.1

267

463

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

7.6

91.7

223

303

F41.8

ICD-10 Finland

Other specified anxiety disorders

4.7

91.6

332

743

N06AG02

ATC

moclobemide; oral

4.0

90.2

381

988

IGY99

NOMESCO Finland

Other psychiatric treatment contact

5.7

89.0

267

483

F32

ICD-10 Finland

Depressive episode

3.2

87.6

504

1677

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

4.2

87.2

356

895

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.5

85.7

438

1333

F99

ICD-10 Finland

Mental disorder, not otherwise specified

5.2

84.9

279

561

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.2

84.9

1037

5269

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.6

83.0

252

462

A06AD11

ATC

lactulose; oral

2.4

81.5

757

3365

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

5.6

80.5

247

459

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

4.9

79.4

275

586

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

7.5

77.8

190

260

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

6.8

77.7

203

306

F41.09

ICD-10 Finland

UNS Panic Syndrome

4.1

77.1

320

815

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

5.0

77.1

259

534

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

76.9

1486

8995

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

76.8

1121

6114

N05AD01

ATC

haloperidol; systemic

4.7

76.1

272

599

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

6.2

76.1

213

353

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.1

75.9

310

778

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

75.1

2220

15359

A04

ICPC

Weakness/tiredness general

2.2

74.9

852

4170

C07AB07

ATC

bisoprolol; oral

1.7

74.5

2168

14923

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.6

74.2

586

2378

R11

ICD-10 Finland

Nausea and vomiting

2.7

73.7

568

2274

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

6.7

73.0

193

296

A01

ICPC

Pain general/multiple sites

2.8

72.4

513

1951

M03BX02

ATC

tizanidine; oral

1.6

71.9

3673

29399

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.3

71.9

395

1267

A02BC05

ATC

esomeprazole; systemic

1.7

71.7

2233

15626

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

71.4

1014

5452

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

6.3

71.1

196

318

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.2

71.1

284

698

S06.0

ICD-10 Finland

Concussion

2.3

71.1

704

3222

L17

ICPC

Foot/toe symptom/complaint

1.8

70.8

1403

8528

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

70.5

2162

15044

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

7.0

70.4

181

267

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

69.8

4303

36079

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

69.4

1404

8586

F90.0

ICD-10 Finland

Disturbance of activity and attention

3.9

68.9

302

807

F39

ICD-10 Finland

Unspecified mood [affective] disorder

5.1

68.6

226

456

D11

ICPC

Diarrhoea

2.2

67.7

818

4098

R03AC02

ATC

salbutamol; inhalant

1.6

67.5

3090

23845

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.2

67.5

784

3860

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

67.4

1242

7344

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.8

67.1

468

1762

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

67.0

1535

9755

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

66.3

1498

9474

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

65.9

1017

5631

P15

ICPC

Chronic alcohol abuse

4.0

65.9

275

704

R02

ICPC

Shortness of breath/dyspnoea

2.3

65.6

703

3334

K59.09

ICD-10 Finland

Constipation, unspecified

3.1

65.1

377

1253

N05BA02

ATC

chlordiazepoxide; systemic

4.9

65.1

221

461

M25.5

ICD-10 Finland

Pain in joint

1.7

64.6

1669

10977

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.5

64.1

564

2422

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

6.0

64.1

184

315

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

63.7

1036

5843

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

7.6

63.6

153

205

J01DB01

ATC

cefalexin; oral

1.7

63.4

4814

42047

N05CD02

ATC

nitrazepam; oral

7.5

63.0

153

208

D01

ICPC

Abdominal pain/cramps general

2.1

62.9

757

3780

R52.9

ICD-10 Finland

Pain, unspecified

2.5

62.9

553

2374

SPAT1307

SPAT

Psychosocial counselling and guidance

2.4

62.3

561

2437

A28

ICPC

Limited function/disability NOS

2.3

62.0

647

3026

SPAT1254

SPAT

Administration of medicine

2.0

62.0

845

4445

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.5

61.4

520

2184

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

61.3

2840

21761

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

52.7

61.0

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

60.8

1118

6577

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.7

60.7

182

329

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.4

60.4

562

2481

A02BC03

ATC

lansoprazole; oral

1.7

60.3

1520

9887

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

5.6

60.1

181

329

A02BC01

ATC

omeprazole; systemic

1.7

60.1

1469

9471

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

59.9

3242

25739

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

59.7

824

4352

N06AB08

ATC

fluvoxamine; oral

4.0

59.7

249

637

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

59.4

711

3537

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

59.0

1802

12370

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.5

58.9

218

497

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

6.7

58.7

154

234

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

5.1

58.5

192

386

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

15.6

58.5

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

58.0

765

3960

L28

ICPC

Limited function/disability (L)

2.1

57.6

746

3833

R52.2

ICD-10 Finland

Other chronic pain

3.6

57.3

276

798

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

9.3

57.0

121

132

SPAT1234

SPAT

Support of social functional capacity

3.3

56.8

309

982

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

7.4

56.4

138

190

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

5.0

55.7

187

385

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

55.4

2877

22445

A02BA02

ATC

ranitidine; systemic

1.9

55.1

983

5703

S18

ICPC

Laceration/cut

1.6

55.0

2124

15426

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

14.7

54.8

P18

ICPC

Medication abuse

10.9

54.3

106

R4110

NOMESCO Finland

Physiotherapy

1.7

53.7

1396

9109

R00.2

ICD-10 Finland

Palpitations

2.4

53.7

480

2070

N05AB01

ATC

dixyrazine; systemic

7.0

53.7

136

197

R05

ICPC

Cough

1.7

53.5

1285

8191

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

53.2

1004

5928

N04AA02

ATC

biperiden; systemic

4.6

53.2

191

423

F32.8

ICD-10 Finland

Other depressive episodes

4.7

52.5

184

397

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

52.4

467

2014

L01

ICPC

Neck symptom/complaint

1.9

52.3

826

4577

N05AL01

ATC

sulpiride; systemic

5.9

51.8

150

260

WX110

NOMESCO Finland

Local anesthesy

1.5

51.4

4076

34720

R74

ICPC

Upper respiratory infection acute

1.6

51.4

1879

13408

N01

ICPC

Headache

2.0

51.0

754

4073

SPAT1260

SPAT

Consultation of another employee

1.8

50.6

992

5924

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

50.5

2337

17621

M79.1

ICD-10 Finland

Myalgia

1.9

50.4

787

4337

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.3

50.3

124

173

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

11.8

50.2

N05AA01

ATC

chlorpromazine; systemic, rectal

5.7

49.9

147

261

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

9.7

49.7

103

108

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.1

49.7

201

500

N30.0

ICD-10 Finland

Acute cystitis

1.9

49.7

774

4262

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

49.5

1071

6592

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

49.4

988

5932

Z00.0

ICD-10 Finland

General medical examination

1.8

49.0

1059

6514

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

7.6

48.9

117

156

P72

ICPC

Schizophrenia

4.5

48.9

182

418

N03AX11

ATC

topiramate; oral

3.5

48.6

241

713

R21

ICPC

Throat symptom/complaint

1.6

48.1

1362

9058

F40.1

ICD-10 Finland

Social phobias

3.6

48.0

230

663

F41.00

ICD-10 Finland

Moderate panic disorder

4.4

47.9

179

413

IBA03

NOMESCO Finland

Psychotherapy evaluation

6.5

47.8

128

201

SPAT1216

SPAT

Assessment of functional ability

2.0

47.4

694

3726

L02

ICPC

Back symptom/complaint

2.1

47.4

584

2925

F33

ICD-10 Finland

Recurrent depressive disorder

4.0

47.4

197

503

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

47.2

1759

12546

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.6

47.0

171

384

P16

ICPC

Acute alcohol abuse

4.8

46.8

161

341

N06BA04

ATC

methylphenidate; oral

3.5

46.8

226

655

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.0

46.8

195

499

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

46.6

628

3266

KMAK

NOMESCO Finland

1.5

46.5

3135

25488

R5140

NOMESCO Finland

Monitoring the use of the aid

2.1

46.4

557

2760

K59.0

ICD-10 Finland

Constipation

2.8

46.3

322

1205

P01AB01

ATC

metronidazole; oral, rectal

1.5

45.7

2191

16543

N17

ICPC

Vertigo/dizziness

2.1

45.6

588

3002

F05.9

ICD-10 Finland

Delirium, unspecified

6.0

45.5

130

222

XA800

NOMESCO Finland

Neuropsychological investigation

2.9

45.4

293

1045

F10.24

ICD-10 Finland

Alcohol depence active use

4.9

45.1

152

315

N05AH02

ATC

clozapine; systemic

3.9

44.9

191

498

R41.0

ICD-10 Finland

Disorientation, unspecified

4.2

44.7

176

427

AA400

NOMESCO Finland

Electroconvulsive therapy

6.8

44.7

115

171

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

44.6

1093

6961

SPAT1301

SPAT

No procedures

1.6

44.6

1670

11893

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

44.5

390

1660

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

44.4

1323

8895

N05AD03

ATC

melperone; systemic

7.0

43.9

111

161

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

43.9

747

4232

M79.7

ICD-10 Finland

Fibromyalgia

3.1

43.7

256

855

UJF32

NOMESCO Finland

Coloscopy

1.6

43.7

1221

8065

M01AB05

ATC

diclofenac; systemic, rectal

1.5

43.6

3688

31212

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

43.6

560

2852

N02AA05

ATC

oxycodone; systemic

2.0

43.4

644

3472

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

11.2

43.4

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

43.2

1430

9862

R07.3

ICD-10 Finland

Other chest pain

2.2

43.2

490

2366

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

7.3

43.1

106

148

IGV01

NOMESCO Finland

Psychiatric network contact

6.5

42.8

114

178

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

42.8

356

1477

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

42.5

1045

6652

K02.1

ICD-10 Finland

Caries of dentine

1.4

42.2

3382

28221

K59.1

ICD-10 Finland

Functional diarrhoea

2.6

42.0

318

1250

SPAT1310

SPAT

Counselling related to known health issue

1.5

42.0

1745

12692

R06.5

ICD-10 Finland

Mouth breathing

2.1

41.6

509

2536

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

41.6

608

3256

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

41.5

1571

11180

J01AA02

ATC

doxycycline; systemic

1.5

41.5

4235

37033

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

7.2

41.4

103

146

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

6.2

41.3

114

187

A11

ICPC

Chest pain NOS

2.4

41.1

380

1663

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

6.0

41.0

116

196

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

5.8

41.0

119

208

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

40.9

705

4007

F41.3

ICD-10 Finland

Other mixed anxiety disorders

4.3

40.7

155

365

D09

ICPC

Nausea

2.6

40.6

324

1313

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

40.6

919

5704

R55

ICD-10 Finland

Syncope and collapse

2.0

40.4

535

2754

N03AF01

ATC

carbamazepine; oral, rectal

2.6

40.2

300

1171

C03CA01

ATC

furosemide; systemic

1.7

40.2

1029

6615

F31

ICD-10 Finland

Bipolar affective disorder

5.1

40.1

131

263

Z01.7

ICD-10 Finland

Laboratory examination

1.9

40.1

630

3463

N05AC02

ATC

thioridazine; oral

3.9

40.0

172

453

Z08

ICPC

Social welfare problem

5.3

40.0

126

243

N05CD08

ATC

midazolam; nasal, systemic

4.4

39.9

149

344

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

39.8

420

1959

-1

NOMESCO Finland

1.5

39.7

2017

15286

IEY01

NOMESCO Finland

Psychoeducation, individual

6.1

39.7

111

185

IER01

NOMESCO Finland

Psychoeducation, group

7.5

39.6

128

F43.00

ICD-10 Finland

Acute stress reaction mild

3.2

39.4

220

712

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

39.3

3080

25420

EBA00

NOMESCO Finland

Extraction of tooth

1.5

39.1

1842

13727

N06AA04

ATC

clomipramine; systemic

4.4

39.1

147

342

M01AH05

ATC

etoricoxib; oral

1.4

39.1

3184

26461

M54.2

ICD-10 Finland

Cervicalgia

2.2

39.0

441

2121

H02AB06

ATC

prednisolone; systemic

1.4

39.0

2395

18844

K30

ICD-10 Finland

Functional dyspepsia

1.9

38.9

583

3148

R05

ICD-10 Finland

Cough

1.7

38.7

989

6350

J01MA02

ATC

ciprofloxacin; systemic

1.5

38.6

1886

14159

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

3.4

38.4

194

583

F22.0

ICD-10 Finland

Delusional disorder

4.9

38.4

130

272

R60.0

ICD-10 Finland

Localized oedema

2.0

38.2

505

2596

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

5.7

38.1

112

199

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

38.1

695

4020

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.1

38.0

450

2209

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

7.6

37.8

120

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

37.8

473

2379

N05AE04

ATC

ziprasidone; systemic

6.4

37.8

101

159

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

37.7

1051

6901

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

6.5

37.7

100

156

R4120

NOMESCO Finland

Occupational therapy

2.3

37.7

368

1656

H03AA01

ATC

levothyroxine sodium; systemic

1.6

37.5

1196

8128

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

37.5

1786

13313

M01AE02

ATC

naproxen; oral, rectal

1.4

37.2

3210

26853

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

9.7

37.1

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

37.0

1868

14086

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

37.0

1144

7715

R06AE07

ATC

cetirizine; oral

1.4

36.9

2495

19930

F45.8

ICD-10 Finland

Other somatoform disorders

2.0

36.8

489

2517

H53.1

ICD-10 Finland

Subjective visual disturbances

2.3

36.7

353

1574

E0000UV

ATC

1.4

36.6

2146

16668

R33

ICD-10 Finland

Retention of urine

2.4

36.4

321

1370

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

36.4

1384

9804

J02AC01

ATC

fluconazole; systemic

1.4

36.4

2269

17832

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

36.2

511

2695

F32.0

ICD-10 Finland

Mild depressive episode

3.1

36.0

207

684

SPAT1243

SPAT

Psychiatric/psychological examination

2.7

36.0

253

953

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

36.0

315

1340

WX290

NOMESCO Finland

Other blockade of nerve

1.4

36.0

2706

22017

S29

ICPC

Skin symptom/complaint other

1.7

35.6

835

5218

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

35.6

2175

17007

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

35.3

375

1753

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3028707) Methadone [Presence] in Urine by Screen method

721

1480

5.31

307.65

3.2

2.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2014

8372

2.96

307.65

2.3

1.7

1.5

1.4

11.50

1830

7498

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3980

24893

2.37

266.80

7.1

6.4

mmol/l

1.2

0.63

3444

21067

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3418

20243

2.33

257.32

2.2

1.9

pmol/l

98.7

96.9

1.36

1819

10792

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5672

42091

2.74

252.46

8.0

7.2

u/l

74.8

75.7

0.85

5437

39808

(3015377) Calcium [Moles/volume] in Serum or Plasma

3037

17219

2.34

251.86

2.8

3.3

mmol/l

2.3

2.4

0.29

2720

15287

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3657

22496

2.29

248.86

6.4

5.8

mmol/l

1.2

0.09

3396

20497

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5958

45921

2.86

234.65

5.1

4.0

pmol/l

14.4

14.6

4.67

5602

42420

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3219

19194

2.24

231.03

3.8

3.1

u/l

29.4

33.2

2.92

3071

18268

(3011288) Drugs identified in Urine by Screen method

800

2386

3.65

225.12

4.1

3.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2166

11078

2.38

222.52

1.6

1.5

nmol/l

20.6

20.5

0.22

1969

9638

(1001926) Buprenorphine [Presence] in Urine by Screen method

861

2771

3.40

214.98

3.0

2.3

—

(3016879) Cocaine [Presence] in Urine

949

3338

3.13

204.07

2.9

2.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4077

27604

2.12

201.50

5.8

5.9

umol/l

10.0

10.9

7.71

3860

26112

(3018418) pH of Serum or Plasma

2577

14742

2.18

197.38

4.1

4.0

7.4

1.38

408

2896

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6490

53890

3.41

194.43

6.3

4.6

mu/l

2.6

2.0

0.65

6166

50317

(3000764) Benzodiazepines [Presence] in Urine

974

3619

2.96

189.44

2.9

2.1

—

(3028300) Cannabinoids [Presence] in Urine

974

3652

2.93

186.17

3.0

2.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3538

23168

2.05

185.79

2.6

2.3

nmol/l

74.2

75.0

0.90

3269

21319

(3027008) Opiates [Presence] in Urine

967

3645

2.91

182.88

2.9

2.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

394

816

5.05

178.83

6.3

5.4

umol/l

384.3

366.3

1.58

355

703

(3024561) Albumin [Mass/volume] in Serum or Plasma

3384

22093

2.02

176.05

4.6

4.8

g/l

36.6

36.2

3.23

3137

20622

(3027944) Amphetamines [Presence] in Urine

944

3585

2.88

175.71

2.9

2.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3969

27581

2.00

170.86

3.5

2.8

ug/l

92.7

101.9

3.27

3724

25932

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2532

15058

2.06

169.22

2.8

2.1

u/l

197.5

215.8

0.54

2397

14232

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2728

16870

2.00

161.73

3.2

2.5

u/l

55.2

57.6

1.46

2557

15635

(3019309) Folate [Moles/volume] in Red Blood Cells

1648

8444

2.24

160.91

1.9

1.7

nmol/l

1172.8

1163.8

0.15

1326

6478

(3013707) Erythrocyte sedimentation rate by Westergren method

5371

42073

2.14

159.61

4.4

3.9

mm/h

10.4

10.6

0.36

5074

39363

(3013650) Neutrophils [#/volume] in Blood by Automated count

4483

32959

1.98

158.57

10.0

9.0

e9/l

4.1

4.0

1.18

3939

28941

(3006315) Basophils [#/volume] in Blood

4011

28743

1.91

149.05

6.7

6.0

e9/l

0.0

0.18

3502

25129

(3013826) Glucose [Moles/volume] in Serum or Plasma

4292

31453

1.92

148.83

6.0

4.4

mmol/l

6.5

1.49

4057

28932

(3013115) Eosinophils [#/volume] in Blood

4117

29773

1.91

148.55

7.0

6.2

e9/l

0.2

0.19

3643

26487

(3001604) Monocytes [#/volume] in Blood

3996

28636

1.91

148.08

6.6

6.0

e9/l

0.6

0.11

3481

25059

(3019550) Sodium [Moles/volume] in Serum or Plasma

6665

58138

3.44

144.89

20.4

13.0

mmol/l

139.4

139.6

11.78

6568

56633

(3023103) Potassium [Moles/volume] in Serum or Plasma

6670

58354

3.41

141.21

20.5

13.1

mmol/l

3.9

2.24

6559

56715

(3031040) Bacteria [#/volume] in Urine by Automated count

4834

37249

1.94

139.21

5.7

4.0

e6/l

2223.6

1501.9

0.22

452

(3019198) Lymphocytes [#/volume] in Blood

4063

29663

1.87

137.79

6.7

6.0

e9/l

2.0

1.30

3608

26459

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

246

427

5.93

135.28

1.6

2.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2209

13376

1.95

133.54

2.4

2.2

mg/l

2.7

2.8

2.67

1906

11482

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5210

41531

1.96

130.85

4.3

2.9

u/l

45.5

42.6

1.40

4970

39376

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1138

5424

2.31

129.42

2.0

2.2

nmol/l

369.1

373.0

0.29

1044

4982

(3044889) 12 lead EKG panel

4825

37634

1.88

127.85

4.0

3.3

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

240

432

5.72

127.01

12.4

11.3

mmol/l

0.6

0.09

229

390

(3022948) Iron [Moles/volume] in Serum or Plasma

1498

8029

2.10

126.73

2.5

umol/l

14.3

13.8

1.93

1409

7466

(42870588) Differential panel, method unspecified - Blood

2830

18821

1.84

126.07

6.1

—

(3019069) Monocytes/100 leukocytes in Blood

3713

27013

1.79

120.69

7.0

6.4

8.3

0.77

3497

25419

(3006504) Eosinophils/100 leukocytes in Blood

3696

26866

1.78

120.37

6.8

6.1

2.7

2.8

2.63

3462

25107

(3022096) Basophils/100 leukocytes in Blood

3601

25993

1.78

119.97

6.8

6.2

0.7

0.30

3370

24315

(3037467) Urinalysis macro (dipstick) panel - Urine

4957

39378

1.86

119.23

5.2

4.0

—

(3018095) Leukocytes [#/volume] in Urine

2821

19086

1.79

116.06

4.5

3.5

e6/l

86.0

86.1

0.00

1988

13066

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1565

8776

2.01

115.66

2.5

2.8

mmol/l

2.4

8.86

1334

7682

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1369

7348

2.07

114.06

2.6

2.4

g/l

2.4

1.93

1272

6816

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2754

18577

1.79

113.88

4.7

3.1

ng/l

55.3

77.4

0.23

1681

10678

(4198724)

214

384

5.72

113.58

3.0

2.9

—

(3018010) Neutrophils/100 leukocytes in Blood

3733

27605

1.74

110.87

6.7

5.9

56.4

56.7

1.13

3515

25951

(3002030) Lymphocytes/100 leukocytes in Blood

3776

28015

1.74

110.82

6.9

6.1

29.2

28.9

0.87

3547

26241

(40758558) Short blood count panel - Blood

2221

14147

1.83

110.45

6.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6284

54759

2.30

108.19

5.1

3.9

mmol/l

5.9

5.8

3.92

5909

50805

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1444

8054

2.00

107.42

3.3

3.6

mmol/l

0.8

0.27

1324

7569

(3002582) Erythrocytes [#/volume] in Urine

2391

15808

1.77

103.45

3.8

3.0

e6/l

73.5

89.3

0.20

1850

11981

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1256

6765

2.04

102.57

2.6

2.5

23.9

23.4

0.64

1115

5830

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6593

59074

2.66

99.62

18.7

12.1

mg/l

19.4

21.7

8.03

5406

46018

(3019150) Specific gravity of Urine by Refractometry

1941

12202

1.81

98.71

4.4

3.6

kg/l

1.0

2.20

242

1787

(3030467) Casts [#/volume] in Urine by Automated count

2212

14467

1.77

98.27

3.6

2.9

e6/l

0.3

0.4

0.72

1664

10772

(3033658) Prothrombin time (PT) actual/Normal

2126

13792

1.77

96.86

4.2

3.9

94.0

93.2

0.72

2059

13438

(3009508) Creatinine [Moles/volume] in Urine

2348

15677

1.74

96.68

3.4

3.2

mmol/l

7.8

7.9

0.26

2020

13427

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1739

10708

1.83

93.94

1.7

1.6

pmol/l

31089556.0

29488168.4

0.04

1515

9136

(44816559) Phosphatidylethanol [Mass/volume] in Blood

391

1272

3.19

93.87

1.6

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1957

12494

1.78

93.61

1.5

1.4

g/l

2.2

2.3

0.79

1136

7968

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2176

14368

1.74

92.30

1.4

1.3

u/ml

1.9

1.7

0.27

550

4036

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1554

9339

1.85

90.34

4.2

3.4

ng/l

154.8

547.2

2.52

1025

6363

(3021589) Normoblasts [#/volume] in Blood

3398

25362

1.65

90.12

10.4

8.9

e9/l

0.0

0.32

2773

20809

(36304419) Bacteria [Presence] in Urine

2160

14331

1.73

89.50

3.5

2.9

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1004

5217

2.08

89.43

2.8

2.5

u/l

31.0

46.8

1.08

864

4499

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5866

50797

1.90

87.91

5.9

4.9

mmol/mol

38.3

38.7

3.04

5538

47714

(3011397) Hemoglobin [Presence] in Urine by Test strip

1971

12946

1.72

83.60

3.9

3.4

—

(3035350) Ketones [Presence] in Urine by Test strip

3656

28181

1.61

82.19

4.2

3.3

estimate

0.0

1.28

667

5356

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6780

62495

2.94

80.14

12.6

9.3

u/l

27.3

26.7

1.23

6651

60602

(3026782) Osmolality of Urine

1612

10113

1.77

79.88

3.0

2.6

mosm/kgh2o

514.6

546.7

6.55

1351

8625

(3023368) Bacteria identified in Blood by Culture

1954

12939

1.70

79.77

5.0

4.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6131

54309

1.95

79.49

15.7

10.8

ml/min/173m2

88.9

87.9

3.27

5105

44592

(3000850) Epithelial cells [#/volume] in Urine

1708

10926

1.74

78.91

2.9

2.5

e6/l

7.0

6.4

0.90

1487

9547

(3014111) Lactate [Moles/volume] in Serum or Plasma

826

4171

2.11

78.79

6.8

7.2

mmol/l

1.4

1.3

0.51

773

4026

(3009261) Glucose [Presence] in Urine by Test strip

3673

28519

1.60

78.71

4.2

3.4

estimate

0.0

0.59

684

5366

(3021601) Nitrite [Presence] in Urine by Test strip

3643

28264

1.59

78.07

5.6

4.6

estimate

0.0

1.08

705

5523

(3026008) Bacteria identified in Urine by Culture

2236

15412

1.66

78.02

3.7

2.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1314

7843

1.83

76.60

2.1

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1917

12762

1.69

76.06

2.0

1.8

mg/l

0.9

1.1

2.16

1376

9500

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

967

5265

1.97

74.66

2.0

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1416

8726

1.78

73.88

3.1

2.6

e6/l

1.2

1.1

0.03

792

4826

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1343

8168

1.79

73.20

3.3

2.7

e6/l

4.5

3.0

3.01

720

4289

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1109

6366

1.88

72.89

6.1

6.2

mmol/l

1.1

1.0

0.93

1020

5949

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

967

5318

1.95

72.35

2.0

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

825

4293

2.04

72.25

4.9

3.9

kpa

6.0

5.8

2.73

791

4157

(3012544) pH of Venous blood

843

4439

2.02

71.40

4.9

3.9

7.4

—

(3002032) Base excess in Venous blood by calculation

818

4281

2.03

70.42

5.0

3.9

mmol/l

1.9

1.8

0.32

669

3484

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1089

6292

1.86

69.88

2.4

2.7

umol/l

6.0

7.5

2.57

884

5396

(3032080) INR in Blood by Coagulation assay

2641

19396

1.58

68.80

8.5

7.6

inr

1.1

1.2

1.00

842

5996

(3002385) Erythrocyte distribution width [Ratio]

5719

50185

1.72

68.53

21.9

14.6

13.6

13.5

1.11

5650

49164

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1761

11745

1.66

68.10

3.3

3.0

ng/l

1183.1

1182.6

0.00

1418

9842

(3020191) Ethanol [Moles/volume] in Serum or Plasma

191

479

4.07

67.77

2.0

1.5

promille

1.3

1.4

0.27

139

367

(3048689) Calprotectin [Mass/mass] in Stool

1316

8125

1.76

67.53

2.2

2.5

ug/g

88.2

122.4

6.22

1010

6458

(3014576) Chloride [Moles/volume] in Serum or Plasma

1026

5936

1.85

65.20

7.4

7.1

mmol/l

104.0

104.6

3.36

997

5815

(3024354) Oxygen [Partial pressure] in Venous blood

690

3523

2.06

63.26

4.3

3.3

kpa

4.8

4.7

0.66

657

3399

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

132

261

5.13

62.96

2.5

2.4

umol/l

139.1

163.8

0.33

141

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

550

2595

2.21

61.81

1.6

1.7

mg/l

2.9

3.8

2.01

456

1772

(3027801) Oxygen [Partial pressure] in Arterial blood

907

5195

1.86

59.12

7.4

7.5

kpa

11.8

12.9

7.59

857

4974

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

907

5196

1.85

59.08

7.4

7.5

kpa

5.1

0.36

861

4974

(3003396) Base excess in Arterial blood by calculation

904

5183

1.85

58.71

7.5

mmol/l

1.2

0.9

1.71

734

4009

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

124

248

5.07

58.39

2.2

2.3

nmol/l

157.1

154.3

0.10

113

211

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1978

14004

1.57

58.21

1.7

1.6

mmol/l

1.5

1.4

4.91

1751

11992

(1002224) Polysomnography panel

573

2813

2.13

58.14

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1645

11156

1.62

58.06

2.6

2.2

—

(40768797) Stomach Pathology biopsy report

1183

7381

1.72

57.54

1.3

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1202

7548

1.71

57.07

2.2

2.3

29.4

29.6

1.11

1167

7316

(3000991) Gas panel - Venous blood

731

3962

1.94

56.30

8.9

8.6

—

(3042517) Benzodiazepines panel - Urine

7.97

55.30

2.7

—

(40761511) CBC panel - Blood by Automated count

6667

62207

2.20

54.87

16.6

11.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

279

1028

2.78

53.42

2.1

3.0

umol/l

30.6

36.0

2.77

239

887

(3016502) Oxygen saturation in Arterial blood

804

4602

1.84

52.13

7.9

8.0

95.1

96.0

2.25

777

4438

(3021387) Prolactin [Units/volume] in Serum or Plasma

596

3098

2.01

51.63

1.7

1.6

mu/l

395.9

296.8

3.73

527

2781

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

577

2971

2.03

51.32

1.7

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1482

10086

1.59

50.55

2.4

2.1

—

(3042936) Bacteria identified in Isolate by Culture

1151

7419

1.66

48.78

2.2

2.0

—

(36660697) Celiac disease serology panel - Serum

858

5107

1.77

48.66

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

2035

14985

1.50

48.14

4.6

3.7

estimate

0.0

0.52

674

5358

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

703

3970

1.86

47.38

3.2

3.4

pmol/l

4.5

1.46

618

3568

(3037522) Nuclear Ab [Titer] in Serum

1265

8413

1.61

47.13

1.4

titre

471.2

556.3

0.94

210

1703

(46235355) HIV 1 and 2 tests - Meaningful Use set

2106

15682

1.49

46.90

2.3

2.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

722

4124

1.84

46.89

2.8

2.2

nmol/l

12.6

12.4

0.22

643

3681

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6272

57822

1.73

46.76

5.0

4.2

mmol/l

2.8

4.38

5898

54197

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

649

3608

1.88

45.90

1.7

1.6

—

(3000494) Fungus identified in Specimen by Culture

1022

6500

1.67

45.33

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

470

2361

2.06

44.59

5.7

4.3

mmol/l

24.4

24.1

1.46

413

2116

(3002173) Hemoglobin [Mass/volume] in Arterial blood

736

4297

1.80

44.36

8.4

g/l

123.1

122.8

0.13

718

4141

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

655

3694

1.85

44.21

3.3

2.2

ug/l

4.7

7.3

5.25

549

3261

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

368

1688

2.24

44.05

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

333

1467

2.33

43.85

1.4

ug/g

319.1

290.7

0.62

191

811

(3014765) Yersinia sp identified in Stool by Organism specific culture

369

1703

2.23

43.51

1.2

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

514

2693

1.98

43.33

1.8

1.6

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

158

476

3.37

42.91

19.2

19.3

nmol/l

1289.6

3406.7

0.54

151

461

(3022217) INR in Platelet poor plasma by Coagulation assay

907

5676

1.69

42.60

22.5

20.1

inr

1.2

0.03

113

874

(42529406) Shigella sp [Presence] in Stool by Culture

368

1713

2.21

42.49

1.2

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

523

2794

1.94

41.62

4.1

3.3

g/l

132.9

130.7

1.51

514

2724

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

334

1508

2.27

41.51

1.4

mg/l

404.8

499.0

6.48

319

1435

(3017143) Hepatitis C virus Ab [Presence] in Serum

1270

8687

1.56

41.38

1.8

1.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

431

2160

2.06

41.10

4.2

3.0

1.6

1.3

3.51

431

2142

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

526

2829

1.93

41.02

4.4

3.5

mmol/l

1.6

0.13

390

2089

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

546

2978

1.90

40.81

4.5

3.5

kpa

5.2

5.1

0.78

512

2762

(3009343) pH of Capillary blood

540

2936

1.91

40.75

4.5

3.5

7.4

0.29

387

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6173

57128

1.62

39.69

4.5

3.9

mmol/l

4.7

8.95

5827

53905

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

300

1324

2.32

39.33

1.3

mmol/l

3.7

0.01

280

1242

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6140

56777

1.61

39.29

4.5

3.9

mmol/l

1.4

1.5

17.61

5782

53387

(3003327) Ova and parasites identified in Stool by Light microscopy

428

2189

2.02

38.56

1.8

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

998

6559

1.61

38.33

2.0

1.7

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

415

2107

2.03

38.15

4.1

2.9

0.7

1.00

403

2014

(3007461) Platelets [#/volume] in Blood

6928

66607

2.76

37.98

27.6

17.7

e9/l

257.9

257.5

0.20

6824

65140

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

470

2501

1.94

37.77

1.1

u/ml

47.7

3.4

—

(3035941) MCH [Entitic mass]

6931

66664

2.77

37.70

27.5

17.6

30.3

30.2

9.18

6882

65901

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

146

5.25

37.53

1.9

2.2

umol/l

13.1

16.0

1.53

146

(3026361) Erythrocytes [#/volume] in Blood

6931

66678

2.76

37.42

27.6

17.7

e12/l

4.5

7.30

6810

65091

(3024731) MCV [Entitic volume]

6930

66668

2.75

37.34

27.5

17.7

90.8

90.4

11.54

6879

65907

(3020779) Urea [Moles/volume] in Serum or Plasma

696

4199

1.73

37.15

7.9

8.0

mmol/l

8.2

8.9

2.14

669

4018

(3010813) Leukocytes [#/volume] in Blood

6931

66696

2.75

37.06

27.7

17.8

e9/l

6.8

6.7

3.86

6816

65069

(3000963) Hemoglobin [Mass/volume] in Blood

6931

66700

2.74

36.98

27.8

17.8

g/l

135.6

136.2

2.86

6883

65928

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1455

10477

1.49

36.75

1.4

1.3

iu/ml

27.6

29.9

0.16

387

3258

(3023323) Follitropin [Units/volume] in Serum or Plasma

669

4004

1.74

36.72

1.5

1.3

iu/l

24.0

25.9

0.80

555

3451

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

294

1327

2.27

36.56

1.3

1.5

e6/l

19.1

27.0

0.24

221

1019

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

293

1327

2.26

36.14

1.3

1.5

e6/l

2478.1

4332.9

0.22

234

1076

(3019060) Gas panel - Arterial blood

520

2909

1.85

35.80

5.3

5.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

505

2801

1.86

35.72

8.1

7.1

mmol/l

24.8

24.4

1.49

481

2611

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

365

1839

2.04

34.24

2.2

1.8

nmol/l

41.3

40.0

0.42

360

1789

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5928

54772

1.50

33.89

4.0

3.5

mmol/l

1.4

1.3

11.63

5531

51318

(3027945) Reticulocytes/100 erythrocytes in Blood

791

5052

1.64

33.88

2.5

2.7

1.8

0.39

687

4498

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1873

14330

1.42

33.85

1.8

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

755

4767

1.65

33.84

2.3

g/l

0.2

3.24

700

4466

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

681

4192

1.69

33.63

2.3

au/ml

24.1

21.4

0.20

297

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

275

1252

2.24

33.50

2.4

1.9

pmol/l

193.3

197.4

0.23

257

1186

(3023511) Choriogonadotropin [Units/volume] in Urine

388

2021

1.97

33.14

1.6

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2706

22085

1.36

32.89

4.4

3.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

635

3858

1.71

32.89

1.3

au/ml

46.1

45.5

0.01

164

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

596

3564

1.73

32.69

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

982

6679

1.55

32.08

2.5

2.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

333

1662

2.05

32.05

2.2

2.4

ug/l

479.6

619.1

0.33

311

1541

(3013139) Helicobacter pylori Ag [Presence] in Stool

633

3872

1.70

31.94

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

2235

17758

1.38

31.90

2.5

2.3

—

(3025941) Bacteria identified in Stool by Culture

597

3614

1.71

31.29

1.3

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

267

1247

2.19

30.56

1.3

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

230

1013

2.31

30.32

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

230

1013

2.31

30.32

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

390

2100

1.91

30.17

4.0

3.3

mmol/l

25.2

25.3

0.18

373

2028

(3006653) Thiamine [Moles/volume] in Blood

276

3.59

29.62

1.2

1.4

nmol/l

145.0

133.8

1.18

276

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1349

9956

1.44

29.12

1.4

1.3

u/ml

7.0

10.2

1.25

499

4107

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

460

2638

1.80

29.10

2.1

1.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

578

3539

1.69

28.98

4.0

ng/l

84.8

85.7

0.09

507

3103

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4997

45209

1.36

28.60

3.9

3.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

415

2321

1.84

28.50

1.4

u/l

8.6

9.6

1.04

321

1905

(21494755) Public health laboratory ask at order entry panel

500

8040

0.59

27.44

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

731

4820

1.58

27.14

1.3

1.2

iu/ml

123.7

152.4

1.10

257

1858

(3020630) Protein [Mass/volume] in Serum or Plasma

581

3623

1.66

27.12

1.8

2.6

g/l

66.3

66.9

1.02

530

3346

(3015235) Bicarbonate [Moles/volume] in Capillary blood

249

1187

2.14

27.07

3.7

3.0

mmol/l

24.5

24.6

0.11

219

1036

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3184

27154

1.31

26.80

4.1

3.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1763

13819

1.37

26.35

4.6

4.3

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

118

401

2.98

26.33

3.4

2.9

—

24.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1758

13775

1.37

26.33

2.5

umol/l

2507.0

3790.8

1.08

1532

12197

(3015171) Extractable nuclear Ab [Units/volume] in Serum

423

2444

1.78

26.06

1.3

u/ml

0.5

1.0

1.13

211

(3023520) Reticulocytes [#/volume] in Blood

575

3612

1.64

26.05

2.6

e9/l

71.9

70.5

0.39

410

2706

(3024928) Oxygen saturation in Venous blood

223

1035

2.19

25.95

4.5

3.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

499

3032

1.69

25.68

7.6

7.5

mmol/l

24.9

24.7

0.38

494

3013

(3003181) Sodium [Moles/volume] in Urine

178

755

2.39

25.61

1.4

mmol/l

57.0

64.3

1.45

139

600

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

418

2432

1.76

25.13

8.9

9.7

mmol/l

24.3

0.23

379

2291

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

774

5255

1.53

25.12

2.4

1.8

—

(3005322) IgE [Units/volume] in Serum or Plasma

634

4132

1.59

24.66

1.4

1.3

u/ml

344.5

215.5

0.37

580

3842

(3005719) IgG [Mass/volume] in Serum or Plasma

674

4477

1.56

24.12

2.2

2.7

g/l

10.1

10.5

2.42

613

4113

(3013512) EKG study

1758

13934

1.35

24.07

4.3

3.4

—

(40768804) Tissue Pathology biopsy report

2757

23289

1.30

23.99

2.1

2.0

—

(3003338) MCHC [Mass/volume]

5656

52655

1.37

23.54

24.0

15.0

g/l

333.0

332.9

0.37

5619

52277

(3043409) Potassium [Moles/volume] in Arterial blood

266

1371

1.98

23.43

5.0

4.2

mmol/l

3.8

3.9

1.80

247

1287

(3052851) Hemolysis interference index of Serum or Plasma

292

1558

1.91

23.23

2.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

217

1049

2.10

22.80

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

245

1239

2.01

22.78

1.5

—

(3020891) Body temperature

331

1852

1.83

22.69

5.8

4.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

469

2903

1.66

22.46

1.7

2.3

—

(3012516) Albumin [Mass/volume] in Urine

1706

13584

1.34

22.37

3.2

3.3

mg/l

537.8

398.7

0.48

1063

8623

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

325

1821

1.82

22.18

1.9

1.8

g/l

0.2

0.16

304

1725

(40761535) Cells panel - Urine sediment

618

4105

1.55

22.05

4.0

3.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

5983

56358

1.39

21.94

19.8

12.8

40.3

40.2

0.22

4629

44368

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

634

4245

1.54

21.82

2.9

2.5

ml/min/173m2

71.7

71.6

0.01

258

1618

(3023410) Appearance of Cerebral spinal fluid

148

623

2.40

21.72

1.4

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1769

14213

1.33

21.68

3.9

4.0

mg/mmol

7.2

9.8

2.05

1110

9117

(3022313) Gas panel - Capillary blood

362

2114

1.75

21.48

4.7

3.7

—

(4010399)

559

3658

1.57

21.29

1.5

1.4

—

(3047181) Lactate [Moles/volume] in Blood

274

1476

1.89

21.19

6.2

6.1

mmol/l

1.3

0.33

239

1292

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

328

1881

1.78

20.72

1.9

1.8

g/l

1.2

0.40

307

1788

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

392

2405

1.67

19.41

1.4

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1668

13484

1.31

19.17

2.4

2.2

—

(1616796) Gas panel - Central venous blood

217

1120

1.97

19.09

3.6

3.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

524

3468

1.55

18.95

1.7

1.9

g/l

1.2

1.4

1.78

484

3206

(3022145) Colonoscopy Study observation

836

6079

1.43

18.90

1.3

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

406

2532

1.64

18.86

3.4

2.6

e6/l

0.4

0.3

0.60

388

2445

(3004716) Salmonella sp identified in Stool by Organism specific culture

542

3624

1.54

18.71

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

221

1159

1.94

18.57

4.2

4.1

kpa

9.1

8.8

1.48

216

1140

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

246

1337

1.87

18.54

1.3

—

(3012501) Base excess in Blood by calculation

220

1153

1.94

18.52

4.2

4.0

mmol/l

2.1

2.4

1.38

151

757

(3013290) Carbon dioxide [Partial pressure] in Blood

220

1154

1.94

18.47

4.2

4.0

kpa

5.0

0.06

215

1136

(3010421) pH of Blood

247

1350

1.86

18.29

4.1

4.0

7.4

0.09

215

1135

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

341

2052

1.70

18.18

2.0

1.8

g/l

1.5

0.23

290

1777

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

202

1036

1.98

18.12

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

476

3126

1.56

17.81

1.1

titre

57.7

184.6

3.59

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

394

2476

1.63

17.76

2.4

2.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

313

1856

1.72

17.61

5.0

3.8

mmol/l

24.6

24.7

0.28

298

1741

(3009445) Proteinase 3 Ab [Units/volume] in Serum

361

2224

1.66

17.60

1.5

1.6

u/ml

10.2

14.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

269

1530

1.79

17.51

1.5

2.3

g/l

9.7

10.4

2.37

225

1317

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

272

1557

1.78

17.33

1.6

2.3

g/l

3.0

3.1

1.94

216

1233

(3008295) Osmolality of Serum or Plasma

120

513

2.36

17.10

1.5

mosm/kgh2o

278.1

281.1

0.74

403

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

389

2461

1.61

17.06

10.2

10.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

230

1260

1.85

16.94

1.5

2.2

g/l

0.0

0.27

210

1173

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

283

1650

1.74

16.93

1.6

2.3

g/l

3.7

3.8

0.46

206

1203

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

283

1651

1.74

16.89

1.6

2.3

g/l

7.1

7.3

1.15

214

1263

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

283

1651

1.74

16.89

1.6

2.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

770

5626

1.41

16.86

1.6

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

305

1822

1.70

16.72

1.1

u/ml

3.8

6.3

0.81

249

(3019225) pH of Specimen

673

4823

1.44

16.40

4.4

3.9

—

(4034850)

298

1782

1.70

16.28

11.1

8.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

269

2.85

15.92

1.0

ng/l

255.3

330.0

2.26

191

(3021901) Oxygen saturation in Capillary blood

167

843

2.00

15.72

3.0

2.7

—

(3049717) Cytology report of Urine Cyto stain

256

1482

1.75

15.72

2.4

—

(3016018) Differential panel - Cerebral spinal fluid

140

664

2.13

15.58

1.2

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

565

3962

1.46

15.43

2.8

2.3

u/l

6745.3

5758.5

0.24

209

1593

(3028626) Oxygen [Partial pressure] in Capillary blood

206

1127

1.85

15.27

4.3

3.5

kpa

8.6

8.5

0.27

194

1039

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1543

12667

1.28

15.22

4.5

4.3

ug/l

1.7

2.5

5.68

1402

11453

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

365

2343

1.59

15.08

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

510

3521

1.48

15.07

2.8

2.9

ng/l

164.9

166.2

0.03

441

3155

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

244

1415

1.75

14.91

1.7

2.3

g/l

0.6

0.9

0.73

214

1247

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

285

2.72

14.86

1.5

1.4

71.8

73.3

0.37

270

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

191

1031

1.88

14.78

1.8

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

227

1296

1.78

14.64

1.5

2.1

g/l

39.2

38.0

2.78

196

1139

(3036180) Methadone [Presence] in Urine

10.69

14.64

2.0

2.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

271

2.75

14.58

1.0

ng/l

34.5

45.7

1.92

189

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

210

1175

1.81

14.50

1.5

2.2

g/l

0.0

0.00

191

1094

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

269

2.73

14.23

1.0

ng/l

800.2

763.1

0.29

187

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

281

1717

1.66

14.19

2.3

2.0

ug/l

1.8

2.2

0.24

250

1539

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

100

430

2.34

14.14

1.7

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

727

5414

1.38

14.14

3.7

4.4

u/l

228.9

239.7

1.55

679

5128

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

230

1339

1.74

13.89

1.2

1.3

u/ml

49.0

35.4

0.57

127

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

279

2.67

13.81

1.5

1.4

mu/l

585.8

430.7

0.78

264

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

206

1164

1.79

13.78

1.5

2.2

g/l

0.0

0.00

191

1092

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

365

2393

1.55

13.77

1.9

2.0

u/l

39.1

38.9

0.09

335

2183

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

8.97

13.77

2.3

1.9

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

10.73

13.75

2.1

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

240

1420

1.71

13.68

2.4

2.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

265

1612

1.67

13.62

1.3

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

142

713

2.01

13.62

1.1

—

3.9

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

276

2.66

13.56

1.6

1.8

umol/l

2.0

1.9

0.63

261

(3048929) Epstein Barr virus Ab [Presence] in Serum

369

2438

1.54

13.45

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

278

1725

1.64

13.24

1.3

u/ml

35.5

37.5

0.03

109

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

303

2.56

13.21

1.0

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

691

5160

1.38

13.19

4.4

3.1

—

(3036489) Thrombin time

339

2208

1.56

13.18

2.0

2.3

20.7

21.3

1.58

295

1878

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

286

1804

1.61

12.75

5.7

5.3

2.0

1.7

2.65

271

1685

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

144

3.28

12.68

1.7

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

285

1799

1.61

12.67

1.6

1.7

titre

130.9

409.4

2.15

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

137

698

1.98

12.65

1.1

—

90.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

297

1899

1.59

12.52

1.9

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

283

1794

1.60

12.37

6.0

5.4

0.9

0.54

269

1680

(3025130) Human papilloma virus identified in Specimen

184

1041

1.79

12.30

1.7

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

559

4078

1.40

12.26

4.3

3.6

mmol/l

1.2

1.22

504

3572

(3041096) Erythrocytes [Presence] in Urine by Automated

1876

16073

1.23

12.26

3.8

2.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

110

524

2.12

12.20

1.3

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

793

6125

1.33

12.11

8.7

5.9

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

293

1883

1.58

12.10

1.4

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1537

12910

1.24

12.07

1.8

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

311

2.46

12.05

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

163

901

1.83

11.79

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

141

3.21

11.73

1.4

1.3

nmol/l

103.2

125.8

0.56

101

(3040151) Glucose [Moles/volume] in Capillary blood

112

548

2.06

11.60

3.9

5.0

mmol/l

7.2

7.1

0.20

461

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

501

6816

0.71

11.57

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

265

1682

1.60

11.55

1.2

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

174

991

1.77

11.41

1.4

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

187

1092

1.73

11.24

2.4

2.2

g/l

135.1

131.4

1.19

135

801

(3035637) Corticotropin [Mass/volume] in Plasma

138

735

1.89

11.23

1.5

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

143

772

1.87

11.17

1.2

1.3

nmol/l

0.2

0.3

—

(40767503) Oxygen content in Capillary blood by calculation

182

1059

1.74

11.09

3.2

2.4

17.0

16.7

0.33

521

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

247

1557

1.61

11.09

1.3

u/ml

1.9

5.7

1.21

156

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

272

1756

1.57

11.04

2.3

2.7

177.0

181.2

0.33

253

1671

(3017181) Myelocytes/100 leukocytes in Blood

607

4567

1.36

11.02

4.3

0.9

0.00

171

1178

(3028271) Lactate [Moles/volume] in Capillary blood

147

805

1.84

10.98

2.7

1.9

mmol/l

1.8

1.7

0.70

142

789

(3024980) IgG subclass 4 [Mass/volume] in Serum

176

1018

1.75

10.96

1.5

1.6

g/l

0.7

0.16

135

779

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

307

2.39

10.95

2.0

1.6

iu/ml

2266707.3

1798501.5

0.13

(3045716) Anion gap in Serum or Plasma

207

2.72

10.94

2.3

2.4

mmol/l

9.1

9.2

0.09

160

(4062490)

123

640

1.94

10.75

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

248

1577

1.59

10.75

1.3

u/ml

5.0

9.7

1.21

255

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

222

1376

1.63

10.69

1.5

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

107

534

2.02

10.54

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.86

10.36

3.8

9.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

129

693

1.88

10.27

1.2

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

578

4370

1.35

10.16

4.4

4.3

0.1

0.2

0.59

160

1092

(3007463) Buprenorphine [Presence] in Urine

5.28

10.10

7.2

6.0

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

121

642

1.90

10.01

1.4

g/l

6.0

6.8

2.27

453

(3036603) Volume of Urine

321

2.29

9.94

1.6

1.5

2152.8

2057.1

0.15

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

193

1178

1.66

9.90

1.5

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

265

1746

1.54

9.86

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

120

642

1.88

9.70

1.4

g/l

0.4

0.82

450

(3028192) IgG subclass 2 [Mass/volume] in Serum

120

643

1.88

9.65

1.4

g/l

2.9

3.0

0.12

454

(3002179) Metamyelocytes/100 leukocytes in Blood

554

4195

1.35

9.65

3.9

4.1

0.6

0.15

128

872

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

122

658

1.87

9.62

1.0

1.1

—

(3008898) HLA-B27 [Presence]

365

2580

1.44

9.59

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

201

1250

1.63

9.59

1.2

1.3

u/ml

19.3

1.9

0.66

(3007566) Smooth muscle Ab [Titer] in Serum

257

1694

1.54

9.56

1.2

1.3

titre

61.9

137.1

1.33

154

(3017509) Phencyclidine [Presence] in Urine

102

3.34

9.55

3.4

1.5

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

485

2.01

9.55

1.3

mmol/l

1.8

2.0

1.24

455

(3044242) Glucose [Moles/volume] in Arterial blood

223

2.52

9.49

2.2

2.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

341

2.21

9.45

1.5

umol/l

27.4

24.5

0.31

328

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1198

10049

1.23

9.26

4.0

3.8

20.8

21.6

0.97

451

4274

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

202

1270

1.61

9.23

1.5

1.4

u/ml

101.1

112.3

1.00

247

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

211

1342

1.59

9.19

1.8

1.5

nmol/l

0.4

0.39

178

1067

(1761868) Lipid panel - Serum or Plasma

2048

23017

0.84

9.08

2.7

2.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

166

998

1.68

9.06

1.3

1.2

u/ml

3.5

4.3

0.50

433

(3025159) Blasts/100 leukocytes in Blood

545

4160

1.34

9.00

4.5

4.4

0.0

0.2

1.06

133

928

(3034770) Mitochondria Ab [Titer] in Serum

251

1670

1.52

8.96

1.2

1.3

titre

1001.7

1021.9

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

164

986

1.68

8.95

1.1

u/ml

3.5

0.02

518

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

199

1261

1.59

8.82

1.5

1.4

u/l

20.1

24.0

1.10

172

1042

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

385

2790

1.40

8.82

1.4

1.3

miu/ml

226.7

226.3

0.01

147

1356

(3051611) Lipemic interference index of Serum or Plasma

486

1.97

8.81

2.9

3.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

434

2.02

8.66

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

338

4673

0.71

8.56

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

135

781

1.74

8.50

1.3

u/ml

70.7

59.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

438

2.00

8.46

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

221

1451

1.54

8.41

3.4

3.9

mg/l

1.5

1.4

0.97

202

1354

(43055514) Macroprolactin [Presence] in Serum or Plasma

226

2.40

8.28

1.5

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

169

2.61

8.08

2.4

2.5

umol/l

28.4

28.0

0.06

115

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

158

968

1.65

8.07

1.2

1.3

—

279.1

—

(3011985) Renin [Units/volume] in Plasma

123

704

1.76

8.06

1.4

1.6

mu/l

60.2

55.7

0.10

113

630

(3022621) pH of Urine by Test strip

469

3561

1.34

8.04

3.4

2.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

210

1378

1.54

8.03

1.2

1.3

u/ml

282.3

252.8

0.78

139

889

(40768443) Skin Pathology biopsy report

322

2304

1.42

7.96

1.2

—

(4027681)

448

1.95

7.96

1.3

1.2

—

(3045414) Leukocytes [Presence] in Urine

349

2534

1.40

7.93

1.8

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

5.84

7.84

1.6

1.4

nmol/l

285.1

653.0

1.68

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

219

1460

1.52

7.80

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

425

1.96

7.73

3.2

4.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

134

796

1.70

7.71

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1121

9510

1.21

7.65

1.8

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

164

1029

1.61

7.63

1.3

1.2

u/ml

3.2

3.3

0.03

349

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

217

1452

1.51

7.61

3.3

3.9

u/ml

0.4

0.3

0.23

120

830

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

275

1930

1.44

7.58

2.2

2.6

95.1

92.7

1.04

253

1782

(3051651) Icteric interference index of Serum or Plasma

313

2.12

7.57

3.0

3.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

119

1989

0.59

7.52

1.3

1.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

309

2.11

7.42

1.2

1.3

44.2

71.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

168

1068

1.59

7.42

2.6

2.2

nmol/l

0.9

0.8

0.46

145

914

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

4.01

7.33

1.3

1.1

mg/l

53.9

48.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

155

970

1.61

7.31

1.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

246

2.25

7.30

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

541

1.82

7.29

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

229

1564

1.48

7.28

1.8

2.0

iu/l

3.5

4.4

0.88

612

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

154

964

1.61

7.26

1.1

—

(3014271) Vancomycin [Susceptibility]

179

2.47

7.22

3.3

2.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

532

1.82

7.06

1.2

u/l

68.9

65.9

0.11

370

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

364

1.99

6.99

1.1

nmol/l

0.4

5.8

2.10

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

252

1768

1.44

6.99

3.0

2.9

g/l

3.6

0.10

231

1680

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

102

579

1.77

6.94

1.2

1.1

mg/l

31.4

38.9

2.68

484

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

494

1.83

6.84

1.1

1.2

—

(3039000) Anion gap in Blood

157

1005

1.57

6.77

8.2

7.5

mmol/l

11.3

11.2

0.05

144

901

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

167

2516

0.66

6.75

1.4

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

218

1498

1.47

6.75

2.1

1.7

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

489

1.83

6.75

1.1

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

562

1.77

6.74

1.1

mg/l

212.8

247.1

1.98

489

(3018572) Chloride [Moles/volume] in Blood

157

1006

1.57

6.74

8.2

7.5

mmol/l

103.8

105.3

2.04

144

902

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

281

2.11

6.74

1.1

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

349

1.99

6.71

1.4

2.3

98.9

97.6

0.14

322

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

219

1509

1.47

6.69

1.8

2.1

mg/l

10.8

0.01

200

1414

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

442

1.87

6.61

1.5

1.3

umol/l

5.1

5.6

0.57

413

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

193

2.34

6.61

3.2

2.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

493

1.82

6.59

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

493

1.82

6.59

1.1

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

100

2.91

6.56

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

182

1213

1.51

6.56

1.7

1.6

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

502

1.80

6.52

1.2

1.1

—

50.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

489

1.81

6.45

1.1

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

139

875

1.60

6.45

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

171

1129

1.53

6.45

1.8

1.6

e6/l

11817.8

12273.9

0.05

128

817

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

183

2.36

6.44

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

490

1.81

6.41

1.1

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

443

1.84

6.27

3.0

3.5

mu/l

23.2

32.5

1.44

420

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

212

2.23

6.17

1.4

1.2

103.5

109.2

0.70

184

(3022493) Free Hemoglobin [Mass/volume] in Plasma

219

2.20

6.14

6.1

7.3

mg/l

99.8

69.4

0.52

162

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

186

1264

1.48

6.13

2.3

1.7

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

140

2.51

6.00

1.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

150

981

1.54

5.94

1.5

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

153

2.43

5.93

1.0

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

103

615

1.68

5.92

7.0

7.1

mg/l

11.0

11.4

0.47

573

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

216

2.18

5.92

1.1

117.9

109.2

0.76

196

(3000492) Spirometry study

721

6017

1.22

5.77

1.5

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

149

2.42

5.76

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

180

2.29

5.76

1.1

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

109

666

1.65

5.75

1.4

pmol/l

403.9

354.7

0.25

518

(3016038) Potassium [Moles/volume] in Urine

286

2.00

5.73

1.3

1.2

mmol/l

30.1

35.9

1.05

253

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

144

2.44

5.68

3.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

144

2.44

5.68

3.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

103

624

1.66

5.63

1.8

1.4

—

(3019977) pH of Arterial blood

254

2.05

5.62

3.1

7.4

0.56

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

159

2323

0.68

5.57

1.7

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

284

2119

1.35

5.56

2.2

1.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1362

12052

1.16

5.56

1.6

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

858

7323

1.20

5.43

2.7

ug/l

0.6

0.7

8.63

537

4384

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

181

1259

1.45

5.35

1.5

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

226

2.09

5.32

1.3

1.5

pmol/l

14.3

14.8

0.22

192

(3034860) Kappa light chains.free [Mass/volume] in Serum

180

1253

1.45

5.30

2.1

3.4

mg/l

40.5

54.4

1.32

148

1014

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

109

681

1.61

5.30

1.9

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

142

943

1.52

5.29

1.5

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

101

620

1.64

5.27

2.6

4.7

u/ml

44.7

58.7

0.30

191

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

145

968

1.51

5.27

1.1

122.5

116.2

1.74

130

883

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

173

1197

1.46

5.26

1.8

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

260

1931

1.36

5.26

2.2

1.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

180

1255

1.45

5.26

2.1

3.4

mg/l

28.3

57.6

1.85

149

1018

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

135

888

1.53

5.26

1.7

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

175

1215

1.45

5.23

1.9

3.4

ratio

1.4

2.0

0.56

109

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

151

2.32

5.15

1.0

1.1

—

(44790049)

601

1.64

5.14

1.4

1.5

—

(44790048)

601

1.64

5.14

1.4

1.5

—

(44806118)

601

1.64

5.14

1.4

1.5

—

(44790047)

601

1.64

5.14

1.4

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

474

1.72

5.07

1.4

1.3

pmol/l

70.9

125.5

0.42

153

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

445

1.74

5.04

1.2

1.3

u/ml

0.6

1.0

0.35

169

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

153

2.29

5.01

1.0

1.1

—

(3021788) Differential panel - Synovial fluid

132

878

1.51

4.91

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

116

752

1.55

4.85

1.7

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

312

1.87

4.82

1.2

u/l

26.4

20.7

0.26

267

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

113

2.48

4.78

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

144

2.30

4.76

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

196

2.10

4.75

2.3

2.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

230

2.01

4.73

1.2

1.1

—

(3017569) Oxygen content in Arterial blood

203

2.08

4.73

2.3

—

(3011648) Oxygen content in Venous blood

418

1.73

4.67

2.2

2.7

10.6

11.3

0.82

418

(3006922) Hepatitis E virus Ab [Presence] in Serum

471

1.68

4.65

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

155

1078

1.45

4.64

1.1

au/ml

12.7

11.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

125

833

1.51

4.63

1.4

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

360

1.78

4.63

1.3

1.2

—

(3002256) Pathology report gross observation

826

7126

1.18

4.62

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

205

2.06

4.62

1.1

1.2

98.4

90.9

0.60

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.21

4.60

1.9

1.5

mg/l

1.0

1.8

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.21

4.60

1.9

1.5

mg/l

0.5

0.9

0.47

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.21

4.60

1.9

1.5

mg/l

1.1

2.6

0.99

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.21

4.60

1.9

1.5

mg/l

2.2

1.9

0.10

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.21

4.60

1.9

1.5

mg/l

1.8

3.1

0.54

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.21

4.60

1.9

1.5

mg/l

0.4

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

108

700

1.55

4.55

1.1

97.4

95.1

0.49

659

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

213

2.02

4.55

1.1

95.5

90.4

0.36

100

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

452

1.69

4.53

1.8

2.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

116

765

1.52

4.52

2.6

3.3

1.1

1.4

0.78

604

(4306422)

147

1019

1.45

4.49

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.15

4.48

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

431

5269

0.81

4.48

1.4

1.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

256

1.92

4.47

1.6

2.5

umol/l

29.5

22.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.53

4.45

1.0

1.1

umol/24h

0.6

0.7

0.63

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

155

2.20

4.45

1.0

1.1

—

(4268621)

107

696

1.55

4.45

2.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

432

1.70

4.44

1.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

293

1.85

4.40

1.4

1.6

nmol/l

4.4

4.7

0.04

230

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

143

994

1.45

4.32

3.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

436

1.68

4.30

1.0

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

101

2.48

4.28

1.8

1.4

nmol/l

0.2

0.3

0.61

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

104

680

1.54

4.24

1.5

1.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.04

4.23

1.9

1.6

mg/l

0.2

1.2

1.29

(3037756) Immunofixation for Serum or Plasma

120

811

1.49

4.20

1.3

1.7

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

470

1.65

4.19

1.5

1.4

umol/l

10.1

11.7

1.91

447

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

131

902

1.46

4.17

2.7

2.9

u/ml

1080.0

1254.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

164

1178

1.40

4.15

5.0

5.6

iu/ml

1571.2

744.3

0.38

150

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

256

1.88

4.14

1.5

1.3

titre

66.0

469.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

249

1.89

4.14

1.5

1.3

titre

245.0

69.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

102

669

1.53

4.11

1.5

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.20

4.05

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

100

656

1.53

4.04

1.5

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

324

1.77

4.03

1.2

u/l

79.4

89.7

0.41

281

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

476

1.62

4.00

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

570

1.57

4.00

1.4

1.7

—

(3017732) Neutrophils [#/volume] in Blood

490

4087

1.21

4.00

3.2

2.6

e9/l

4.0

4.1

0.72

389

3340

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

183

2.03

3.97

2.0

2.1

ug/l

49.6

73.1

1.26

177

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

101

667

1.52

3.96

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

100

659

1.52

3.96

1.5

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

123

846

1.46

3.96

2.1

1.7

titre

1405.7

1852.1

—

(3000034) Microalbumin [Mass/volume] in Urine

462

1.63

3.96

2.8

2.9

mg/l

84.0

54.8

0.32

345

(3005988) Vibrio sp identified in Specimen by Organism specific culture

100

660

1.52

3.94

1.5

1.4

—

(3033942) Copper [Moles/time] in 24 hour Urine

3.64

3.92

1.3

1.1

umol/24h

2.2

0.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

112

2.33

3.91

1.4

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

357

1.71

3.91

1.3

1.5

u/l

9.3

5.9

0.74

306

(3022475) Manganese [Moles/volume] in Blood

3.26

3.90

1.2

1.3

—

(3037121) Protein [Mass/volume] in Urine

232

1778

1.32

3.90

3.1

3.2

g/l

0.3

0.10

107

771

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

235

1.88

3.81

1.4

1.2

g/l

0.3

0.24

186

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.80

1.9

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.84

3.78

1.0

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

124

864

1.44

3.75

2.0

1.7

—

(3006576) Bicarbonate [Moles/volume] in Blood

160

2.07

3.75

4.8

6.2

mmol/l

25.2

24.6

0.39

149

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

103

692

1.50

3.75

1.0

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.64

3.72

1.1

1.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

470

1.60

3.72

1.2

1.3

titre

53.3

227.6

—

101

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

268

1.80

3.63

2.4

umol/l

48.8

51.3

0.18

229

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

584

1.53

3.63

2.1

2.2

mg/l

30.3

24.0

0.29

159

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

232

1.86

3.63

1.4

1.8

143.8

160.6

0.79

217

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

204

1.92

3.61

1.2

—

(3044941) Cell count panel - Synovial fluid

112

772

1.46

3.60

1.6

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

102

691

1.48

3.58

1.7

1.5

iu/ml

34.8

29.9

—

(3029075) Extractable nuclear Ab panel - Serum

177

1.98

3.57

1.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.55

3.48

1.9

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

410

1.62

3.42

1.1

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

443

1.59

3.37

1.4

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

169

1270

1.34

3.31

2.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

141

1031

1.38

3.29

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.30

3.25

1.3

mg/l

0.9

134.0

1.20

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

471

1.56

3.25

1.3

1.4

nmol/l

1.5

1.4

0.13

422

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

256

1.76

3.24

1.0

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.34

3.23

2.7

2.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.58

3.20

16.6

10.7

mmol/l

4.9

6.0

1.00

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

5.34

3.19

1.1

1.2

mmol/l

—

(3000012) Reticulocyte production index

228

1.80

3.19

1.2

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

836

7428

1.14

3.18

1.9

1.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

458

1.56

3.17

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.31

3.16

1.0

1.2

u/ml

0.0

0.43

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

161

1212

1.34

3.14

3.5

3.7

57.7

56.8

0.41

161

1212

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

151

1.99

3.13

2.2

1.6

—

(3042631) Mycobacterium sp identified in Specimen

549

1.50

3.10

2.9

2.7

—

(44813793)

470

1.54

3.07

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

559

1.49

3.06

1.2

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

132

2.05

3.06

1.3

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

195

1.85

3.05

1.6

2.4

e6/l

206.0

179.5

0.30

108

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

5.84

3.02

9.3

7.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

132

971

1.37

3.01

1.1

iu/ml

14.9

10636.2

0.64

253

(3010144) Erythrocytes [#/volume] in Synovial fluid

425

1.56

2.99

1.5

1.4

e6/l

88984.9

74932.5

0.08

296

(3027456) Digoxin [Moles/volume] in Serum or Plasma

645

1.45

2.97

3.5

3.1

nmol/l

0.8

0.13

494

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

539

1.49

2.95

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

101

2.18

2.92

1.1

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

500

1.51

2.92

1.1

mg/l

288.8

287.9

0.03

454

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

509

1.50

2.89

1.5

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

101

716

1.42

2.87

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.93

2.85

1.1

1.2

u/l

13.1

15.7

0.12

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

290

1.66

2.83

1.6

1.4

u/ml

24.0

20.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

215

1.77

2.83

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

215

1.77

2.83

1.2

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

512

1.49

2.82

1.2

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

130

2.00

2.79

1.4

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

695

1.42

2.79

1.8

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

377

1.57

2.79

1.9

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

579

1.46

2.79

2.1

1.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

484

1.49

2.72

1.9

2.2

11.9

14.0

1.04

234

(40761536) Microorganisms panel - Urine sediment

577

5057

1.15

2.70

4.7

3.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.60

2.70

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

421

1.52

2.68

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.33

2.64

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

455

1.50

2.63

3.0

2.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

213

1.74

2.62

2.0

2.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.46

2.61

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.55

2.61

1.0

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

385

1.54

2.57

1.9

2.0

g/24h

0.3

1.7

—

(3007919) Fasciola sp Ab [Titer] in Serum

5.46

2.54

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.03

2.52

1.3

1.4

nmol/l

20.4

21.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

460

1.48

2.51

2.5

3.3

56.7

57.3

0.07

300

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.27

2.50

1.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

145

1118

1.30

2.47

1.2

—

(3023419) Bacteria identified in Sputum by Culture

561

1.43

2.47

2.5

2.7

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

123

1.95

2.44

1.3

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

159

1.83

2.43

1.5

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

440

1.48

2.41

1.9

2.6

e6/l

483.6

504.6

0.12

369

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

273

1.62

2.39

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

499

1.45

2.38

2.8

4.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

377

1.52

2.36

2.4

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

361

1.53

2.36

1.4

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

402

1.50

2.35

1.1

u/l

1.0

1.1

0.37

178

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.26

2.34

1.1

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

214

1.69

2.31

1.0

1.1

u/ml

1.2

3.6

1.02

119

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

268

1.61

2.31

1.1

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.86

2.30

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

404

1.49

2.30

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

404

1.49

2.30

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

404

1.49

2.30

1.4

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

340

1.53

2.28

2.4

2.7

42.8

41.6

0.16

120

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.12

2.28

2.7

3.1

mg/l

76.4

22.9

—

(3003694) ABO and Rh group [Type] in Blood

1934

18255

1.08

2.28

1.5

1.6

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

4.62

2.27

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

127

1.89

2.25

1.4

1.1

—

(3011412) CD3 cells [#/volume] in Blood

606

1.39

2.24

2.0

2.5

e9/l

1.4

1.2

0.92

363

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

318

1.54

2.23

1.5

1.6

u/l

2.4

4.9

1.48

165

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

105

786

1.34

2.23

1.0

1.1

g/l

1.5

0.73

705

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

117

890

1.32

2.23

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

232

1.64

2.22

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

137

1066

1.29

2.21

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

179

1.74

2.21

3.9

4.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

279

1.58

2.21

1.3

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

5.56

2.21

1.2

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

280

1.57

2.19

1.1

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

299

3512

0.84

2.18

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.07

2.16

1.2

1.3

ng/l

59.1

59.7

—

(3045424) Erythrocytes [Presence] in Urine

123

948

1.30

2.15

1.6

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

266

1.58

2.13

2.5

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

122

942

1.30

2.11

2.3

3.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

283

1.56

2.10

1.4

1.7

nmol/l

1.4

0.06

225

(3032057) Clostridioides difficile [Presence] in Stool

2.00

2.10

1.6

2.0

—

(4094501)

172

1388

1.25

2.08

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.26

2.07

1.1

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

269

1.56

2.05

2.5

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

132

1.82

2.03

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

684

6196

1.12

1.97

4.5

4.0

31.3

32.0

0.80

518

4433

(3046861) Legionella sp Ag [Presence] in Urine

3.75

1.93

1.8

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

361

3145

1.16

1.92

2.5

3.0

u/ml

38.6

46.9

0.58

354

3039

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

549

1.37

1.89

1.7

2.1

33.4

32.4

1.25

543

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

511

4569

1.13

1.85

3.0

4.1

ug/l

6.5

27.3

1.89

382

3577

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

100

1.90

1.85

6.1

5.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

620

1.34

1.85

1.2

1.4

mmol/l

13.4

11.8

0.75

128

(3024869) Neuronal Ab [Presence] in Serum

1.98

1.84

1.2

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

162

1320

1.23

1.84

1.3

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

425

1.42

1.83

1.9

2.7

e9/l

0.2

0.28

366

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.83

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.50

1.83

1.2

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

138

1.74

1.79

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

109

1.84

1.76

1.5

1.7

ug/l

0.4

0.12

(3000330) Specific gravity of Urine by Test strip

284

2448

1.17

1.76

3.8

3.1

—

(3024263) Appearance of Synovial fluid

256

1.53

1.75

2.4

1.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.44

1.75

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.90

1.75

1.6

1.5

—

(3018001) Oat IgE Ab [Units/volume] in Serum

2.22

1.73

1.2

1.0

u/ml

0.2

0.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

465

1.38

1.71

1.5

28.2

33.8

0.58

285

(21491868) Cryoglobulin [Mass/volume] in Serum

226

1.55

1.70

1.2

g/l

—

0.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.86

1.65

2.9

—

(3022689) Creatine [Moles/volume] in Urine

157

1.66

1.65

1.7

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.80

1.65

2.9

3.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

189

1585

1.20

1.64

2.8

3.6

u/ml

248.3

3323.9

1.04

169

1350

(3035285) Chloride [Moles/volume] in Venous blood

505

1.35

1.61

2.8

2.3

mmol/l

105.7

105.4

0.25

496

(3041354) Potassium [Moles/volume] in Venous blood

505

1.35

1.61

2.8

2.3

mmol/l

4.0

0.13

496

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

303

1.45

1.60

2.4

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.95

1.59

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.00

1.58

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

439

1.37

1.57

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.93

1.54

1.1

1.0

u/ml

0.3

0.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.33

1.52

1.2

3.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

334

0.60

1.52

1.1

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

442

1.36

1.51

1.1

1.2

—

45.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.90

1.49

1.1

1.2

26.4

60.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

101

1.78

1.48

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

522

1.32

1.47

2.4

42.2

45.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

583

1.31

1.47

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.22

1.46

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

190

1615

1.18

1.45

1.1

u/ml

1.0

1.6

0.95

645

(3042111) Morphology [Interpretation] in Bone marrow Narrative

726

1.27

1.44

1.5

1.7

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

244

1.48

1.44

1.1

u/l

33.1

19.7

0.32

188

(3030313) Adrenal Ab [Titer] in Serum

1.92

1.43

1.0

1.1

—

(3013762) Body weight Measured

2.73

1.43

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.31

1.42

3.1

1.7

umol/l

54.8

43.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

413

1.36

1.42

1.1

iu/ml

11.0

9.0

—

111

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

431

1.35

1.40

1.1

1.2

u/ml

40.6

43.5

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

246

1.47

1.39

1.1

u/l

101.9

79.5

0.45

194

(3014148) Varicella zoster virus Ab [Titer] in Serum

124

1018

1.22

1.38

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.77

1.38

1.6

1.7

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.20

1.36

1.6

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.94

1.36

1.0

—

(3044927) Protein electrophoresis panel - Urine

408

1.35

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

234

2681

0.87

1.35

1.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.14

1.33

1.0

1.3

—

(4015189)

105

1.72

1.32

1.9

2.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

168

1.55

1.31

1.2

1.5

ug/l

9.9

8.4

0.96

168

(3039443) Prostate specific Ag panel - Serum or Plasma

952

0.79

1.29

1.4

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

1.84

1.29

1.1

1.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.78

1.28

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

177

1.53

1.28

5.2

9.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

161

1370

1.18

1.25

1.1

u/ml

1.3

2.1

0.61

344

(3025018) Bordetella pertussis Ab [Titer] in Serum

380

1.34

1.24

1.3

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

220

1.46

1.23

1.0

—

(3012898) Urea [Moles/volume] in Urine

1.91

1.22

1.7

mmol/l

190.8

176.2

0.14

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.91

1.22

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

139

1171

1.19

1.22

1.1

u/ml

3.0

4.1

0.33

449

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.97

1.22

1.0

1.1

umol/24h

1.5

1.7

0.77

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

140

1.57

1.19

1.1

u/ml

0.3

1.7

1.01

(3023430) Cat dander IgE Ab [Units/volume] in Serum

130

1092

1.19

1.1

u/ml

4.5

5.3

0.28

442

(3033705) Calcium.ionized [Moles/volume] in Venous blood

488

1.29

1.19

2.9

2.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

341

1.35

1.17

1.8

—

(4146454)

463

1.30

1.17

2.3

2.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

257

1.40

1.15

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

229

2019

1.14

1.5

1.6

iu/ml

6.8

3.3

0.20

401

(3001964) Herpes simplex virus Ag [Presence] in Specimen

175

1.49

1.12

1.2

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

168

1454

1.16

1.10

1.1

u/ml

5.9

6.2

0.08

763

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.76

1.06

3.2

2.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

506

1.27

1.06

1.1

u/ml

10.0

2.1

0.37

144

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.92

1.06

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

211

1.42

1.05

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

395

1.29

1.00

1.6

1.5

—

(3020650) Glucose [Presence] in Urine

176

0.57

0.99

1.2

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.67

0.97

1.5

1.6

ng/l

122.4

113.8

0.14

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.95

0.97

1.0

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.85

0.96

1.1

—

(3002619) Bacteria identified in Specimen by Culture

124

1.53

0.96

1.1

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

116

1.55

0.96

1.6

1.2

g/l

39.3

38.3

0.15

(3004451) EKG impression Narrative

216

1.39

0.95

1.5

1.3

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.89

0.94

1.0

1.1

—

23.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

435

1.27

0.93

2.0

2.7

e6/l

900.1

770.8

0.50

182

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

533

0.77

0.92

2.5

1.6

—

(3001556) Androgen free Index in Serum or Plasma

110

1.55

0.90

1.6

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

158

1389

1.14

0.88

1.1

u/ml

1.1

1.2

0.07

578

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

228

1.36

0.88

1.9

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

228

1.36

0.88

1.9

1.5

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.00

0.87

1.3

1.1

mmol/l

8.7

8.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.00

0.87

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

255

1.33

0.86

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

111

1288

0.86

0.85

1.1

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.67

0.85

1.2

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.63

0.84

1.1

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

596

1.21

0.84

1.6

55.9

55.5

0.03

380

(3012565) Volume of 24 hour Urine

283

1.31

0.83

1.8

2.3

1944.5

2027.1

0.17

261

(40758292) HTLV I+II Ab panel - Serum

111

0.54

0.83

1.0

1.4

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.64

0.81

1.1

1.0

u/ml

0.1

0.9

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.57

0.81

1.0

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

1.70

0.80

1.0

u/ml

57.2

9.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.67

0.78

1.4

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.62

0.78

1.4

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

787

1.17

0.77

1.2

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

413

1.24

0.75

1.5

1.4

e6/l

16492.8

73548.0

1.83

241

(3045142) Bone marrow Pathology biopsy report

504

1.21

0.75

1.2

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

232

0.69

0.74

1.6

1.7

—

(3014891) Appearance of Pleural fluid

1.67

0.74

2.9

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

387

1.24

0.74

1.2

1.3

—

(4024509)

505

1.21

0.73

1.6

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

245

1.31

0.73

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.00

0.72

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.80

0.72

1.4

1.5

umol/24h

273.7

320.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.80

0.72

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.61

0.72

1.8

2.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.58

0.71

6.3

6.1

ug/min

37.0

49.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.75

0.71

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

309

1.26

0.70

1.1

u/ml

13.5

7.1

—

(4212803)

1.71

0.70

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

144

1.39

0.67

1.6

1.2

57.3

52.1

0.23

122

(3034426) Prothrombin time (PT)

231

1.30

0.67

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

761

1.16

0.67

1.3

1.2

u/l

25.8

41.3

1.14

657

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

604

1.18

0.66

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.79

0.66

1.4

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.79

0.66

5.0

2.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

150

1346

1.12

0.66

1.2

1.3

ug/l

3.4

3.9

0.65

137

1232

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

745

0.84

0.66

1.2

1.1

—

2.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.61

0.65

2.3

3.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

358

1.23

0.65

1.2

1.1

u/ml

3.0

17.6

—

(44806071)

1.47

0.64

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.72

0.64

6.4

11.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

551

1.18

0.64

1.4

nmol/l

24.2

31.9

1.67

492

(3023199) Leukocytes [#/volume] in Pleural fluid

469

1.20

0.63

1.5

1.4

e6/l

7314.5

2405.3

0.50

336

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

506

1.19

0.62

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

415

1.21

0.62

2.6

2.2

—

(3028433) Virus identified in Specimen by Culture

173

1.33

0.61

1.0

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.67

0.61

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

254

2743

0.92

0.61

1.3

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

147

1.36

0.61

1.5

2.0

e6/l

10348.0

17943.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

274

2949

0.93

0.61

1.4

1.5

—

(3015183) Erythrocyte sedimentation rate

390

0.79

0.60

1.3

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

407

1.21

0.60

1.4

2.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

853

1.14

0.60

2.4

2.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

255

2751

0.92

0.60

1.3

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

371

1.21

0.60

5.0

6.9

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

255

2749

0.92

0.59

1.3

1.4

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.54

0.59

3.4

3.1

mg/l

2.0

1.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

192

1.30

0.59

1.2

1.8

—

19745.4

—

(44806420)

1.44

0.58

2.3

2.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.58

0.0

1.2

—

(4281824)

566

1.17

0.58

1.1

—

(3033799) Differential panel - Peritoneal fluid

140

1.36

0.58

1.7

2.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.48

0.57

1.0

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

1.48

0.57

1.2

1.0

u/ml

1.4

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

444

4206

1.06

0.56

1.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.58

0.56

26.0

7.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

699

0.86

0.55

1.3

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

121

1087

1.12

0.55

5.5

3.9

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

133

1.35

0.55

1.1

1.3

—

(3044007) Cell count panel - Peritoneal fluid

133

1.35

0.55

1.6

2.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

505

1.17

0.54

1.4

1.5

g/l

32.3

33.9

0.43

459

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.58

0.54

3.5

2.4

—

(3024471) HLA-A [Type]

204

1.28

0.54

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

349

1.20

0.53

1.1

miu/ml

1682.8

1513.6

0.47

349

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

125

1128

1.11

0.53

2.3

2.5

ug/min

125.9

115.6

0.06

713

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

255

2732

0.93

0.53

1.3

1.4

—

(40768806) Pleura Pathology biopsy report

405

1.19

0.52

1.6

1.5

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

143

1.33

0.52

1.1

—

0.6

—

(3012441) Differential panel - Pleural fluid

396

1.19

0.52

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

1.43

0.52

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

323

1.21

0.51

1.0

1.1

100.2

93.1

0.99

260

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.46

0.50

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

510

1.16

0.49

1.0

1.1

u/ml

4.0

2.6

0.17

120

(3002331) Protein [Mass/volume] in Peritoneal fluid

101

1.39

0.49

1.1

1.4

g/l

34.8

25.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

473

1.16

0.49

1.0

u/ml

0.3

1.9

0.81

(3035880) pH of Pleural fluid

198

1.26

0.49

1.1

1.4

—

(3025315) Body weight

1.56

0.48

5.3

3.8

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

212

0.75

0.48

6.4

6.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

212

0.75

0.48

3.3

3.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

107

965

1.11

0.48

1.1

1.0

u/ml

0.2

0.5

0.86

203

(40768800) Prostate Pathology biopsy report

688

0.87

0.47

1.1

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

283

2665

1.06

0.46

2.3

2.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

133

1216

1.10

0.46

1.9

2.2

umol/l

6.5

6.4

0.02

109

893

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.43

0.45

1.0

1.2

mmol/l

20.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

384

1.17

0.45

1.8

1.9

u/field

2.3

1.9

0.21

173

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

121

0.66

0.45

1.0

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

440

1.16

0.45

1.2

1.1

ratio

1.1

1.0

0.37

165

(3045788) Cell count panel - Pleural fluid

375

1.17

0.45

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

219

1.23

0.45

1.1

—

(3024932) HLA-DR beta [Type]

201

1.24

0.44

1.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

896

1.11

0.43

3.3

3.7

u/ml

16.7

28.8

4.75

870

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.41

0.43

1.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.43

0.42

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

221

1.22

0.42

1.0

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.40

0.42

1.1

—

(3042733) HLA Ab [Presence] in Serum

203

1.23

0.42

6.0

5.0

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.41

0.0

1.3

—

16.3

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

6.4

—

2.6

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.40

0.0

1.1

—

34.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.40

0.0

3.8

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

186

1.24

0.40

2.3

2.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.40

0.0

1.2

—

69.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

793

0.89

0.40

1.4

1.6

mmol/l

7.4

7.6

0.29

493

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

368

0.84

0.39

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

104

0.67

0.39

1.1

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.39

0.0

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

251

1.20

0.39

1.3

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

251

1.20

0.39

1.3

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

251

1.20

0.39

1.3

1.9

—

(3036048) Francisella tularensis Ab [Titer] in Serum

148

0.74

0.38

1.2

1.1

—

205.0

—

(40765096) Chromosome analysis panel by Banding

147

0.75

0.37

1.3

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.30

0.37

1.0

—

(4133840)

180

0.78

0.36

1.4

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.27

0.36

1.8

1.9

—

(40768446) Kidney Pathology biopsy report

235

1.19

0.36

2.2

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

320

0.84

0.35

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

136

1267

1.07

0.34

1.1

—

(3017704) Immunofixation for Urine

227

1.19

0.34

1.0

1.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

283

1.17

0.34

1.5

1.6

u/field

3.5

3.7

0.04

205

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

107

988

1.08

0.34

1.4

mmol/l

7.2

7.0

0.29

733

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.32

0.33

1.1

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

188

0.80

0.33

2.6

3.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

261

2487

1.05

0.33

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.35

0.31

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

165

1.21

0.31

1.6

2.3

e6/l

253.2

918.5

—

120

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

286

1.15

0.31

9.8

6.6

u/ml

34.0

9846.4

0.51

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.31

0.30

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.25

0.29

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

363

1.13

0.29

1.8

1.9

—

(3002523) Influenza virus A Ag [Presence] in Specimen

135

1269

1.07

0.28

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

232

1.16

0.28

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

251

1.16

0.28

1.3

1.9

—

(3000285) Sodium [Moles/volume] in Blood

1.27

0.27

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.23

0.27

1.4

2.6

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.30

0.26

3.5

2.6

mmol/l

0.6

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

851

8340

1.02

0.25

1.4

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.22

0.25

6.1

5.3

g/mol

37.3

56.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.26

0.24

1.0

2.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.71

0.24

1.2

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

121

1143

1.06

0.24

4.0

3.2

mg/l

19.5

25.2

1.56

687

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

106

1.23

0.23

1.0

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

100

1062

0.94

0.22

3.5

2.4

13.0

13.1

0.88

100

1047

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.25

0.22

1.0

1.2

—

(40768441) Liver Pathology biopsy report

410

1.10

0.22

1.2

1.4

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.21

0.0

1.0

—

0.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.21

0.0

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.21

0.0

2.2

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.21

0.0

1.5

—

185.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

479

1.09

0.20

1.3

1.8

—

(3025577) Chromium [Mass/volume] in Blood

230

1.13

0.20

2.2

2.0

ug/l

2.2

2.6

0.31

197

(3016135) IgD [Mass/volume] in Serum

0.00

0.20

0.0

1.3

—

74.3

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

108

1.20

0.20

1.2

1.5

26.4

25.3

0.05

100

(3048879) Bone marrow aspiration report

115

0.78

0.20

1.0

2.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

271

0.89

0.20

17.6

27.3

ug/l

115.6

117.1

0.02

225

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.18

0.19

1.3

1.2

—

10.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

241

1.12

0.19

2.3

2.0

ug/min

10.9

132.2

—

(3047189) Immunofixation for 24 hour Urine

195

0.87

0.17

1.2

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

1.11

0.17

1.3

1.2

—

(40768793) Breast Pathology biopsy report

137

1316

1.04

0.16

1.4

1.3

—

(21494434) Karyotype in Bone marrow

388

1.08

0.16

1.1

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

196

1.12

0.16

1.5

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

196

1.12

0.16

1.5

2.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

277

0.90

0.16

1.1

—

(3004775) Volume in Urine collected for unspecified duration

370

0.92

0.16

2.6

2.3

664.1

628.3

0.22

257

(3016750) Collection duration of Urine

283

1.10

0.15

2.5

2.2

min

519.2

492.5

0.95

214

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

197

1.12

0.15

1.5

2.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

140

1.14

0.15

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

140

1.14

0.15

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

140

1.14

0.15

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

317

0.91

0.15

1.9

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

207

1.11

0.15

3.3

3.8

—

(40757373) Influenza virus identified in Isolate

108

0.83

0.13

1.7

1.6

—

(4035726)

438

4453

0.98

0.12

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

172

1.10

0.11

1.2

1.1

—

(40768795) Lymph node Pathology biopsy report

506

0.95

0.11

1.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

115

1.13

0.10

1.2

1.6

3.5

3.4

0.02

(4211845)

290

0.93

0.10

3.1

2.8

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.09

0.09

1.0

1.2

—

2.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.04

0.09

1.0

—

3.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.11

0.09

1.2

—

(3019174) dRVVT (LA screen)

1.08

0.08

1.3

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

156

1.09

0.08

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.03

0.07

1.1

1.5

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.86

0.07

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

266

0.94

0.07

2.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.05

0.07

6.0

7.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.05

0.07

1.4

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

206

1.07

0.07

1.1

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

224

2270

0.99

0.06

1.4

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

119

1.09

0.06

1.0

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

131

0.92

0.05

3.4

2.4

—

(3013637) Mi-2 Ab [Presence] in Serum

129

1.09

0.05

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

129

1.09

0.05

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

129

1.09

0.05

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

129

1.09

0.05

1.2

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

141

0.92

0.05

1.7

2.8

ng/l

96.7

130.4

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

179

1.06

0.05

1.2

1.1

u/ml

70.5

53.6

0.34

173

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

917

0.98

0.04

2.3

3.6

u/ml

112.5

566.5

0.93

841

(3037556) Urate [Mass/volume] in Serum or Plasma

140

0.93

0.04

1.7

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

101

1.09

0.04

16.2

7.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

291

0.96

0.04

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

291

1.03

0.02

3.5

3.2

mg/l

9.3

8.0

0.20

227

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

510

0.98

0.02

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

168

0.95

0.02

1.1

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

107

0.93

0.02

1.7

2.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

220

2207

1.00

0.00

1.4

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

244

1.02

0.00

2.3

2.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

137

1.02

0.00

1.4

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

126

1.03

0.00

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

113

0.97

0.00

16.2

7.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

408

1.00

0.00

1.1

—

(3005033) Fetal Nuchal fold Thickness US

220

2200

1.00

0.00

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

216

1.02

0.00

6.1

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

422

1.00

0.00

1.4

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

256

1.02

0.00

2.7

3.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.6

—

(4038314)

0.91

0.00

1.2

1.3

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.95

0.00

3.8

6.4

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.4

—

2175.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.91

0.00

1.4

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.94

0.00

2.0

2.4

u/field

0.2

0.7

—

(3032641) Amino acids panel - Urine

0.00

0.0

1.5

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1815.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.99

0.00

1.1

1.3

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.9

—

12.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.95

0.00

1.0

1.1

—

(3006598) pH of Arterial cord blood

0.96

0.00

1.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.91

0.00

1.8

1.2

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_INSOMNIA and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_INSOMNIA	1.584 [1.38, 1.82]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.141

During the follow-up period (1.1.1998 — 31.12.2019), 1815 out of 17928 females with F5_INSOMNIA died.

Males

Parameter	HR [95% CI]	p-value
F5_INSOMNIA	2.16 [1.89, 2.47]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.034

During the follow-up period (1.1.1998 — 31.12.2019), 2637 out of 16039 males with F5_INSOMNIA died.

Mortality risk

Mortality risk for people of age

years, who have F5_INSOMNIA.

N-year risk	Females	Males
1	0.141%	0.458%
5	0.795%	2.887%
10	2.327%	6.982%
15	4.446%	13.114%
20	7.884%	21.564%

Relationships between endpoints

↥

Index endpoint: F5_INSOMNIA – Insomnia

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Insomnia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints